Embera Neurotherapeutics
Embera Neurotherapeutics is a specialty pharmaceutical company based in Sudbury, MA, focused on developing innovative treatments for addiction, specifically targeting cocaine and nicotine use disorders. Their lead product, EMB001, aims to treat addiction by moderating activity in the stress response system, potentially reducing cravings and loss of control associated with substance use.
With recent advancements, including the completion of Series B financing and the receipt of grants to support Phase 2 clinical studies, Embera is positioned to make significant contributions to the treatment of a broad range of addictions. The company's leadership emphasizes the importance of proactive measures in addressing the rising concerns of stimulant use alongside the ongoing opioid crisis.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.